FDA Investigator Ana S Cabrera
Ana S Cabrera has inspections in 3 countries as of 13 Oct 2023. Ana S Cabrera has collaborated with a combinined 2671 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
45
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan,
United States of America
Co-Investigator(s):
A Williams,
Abby Lmozeke Baker,
Alberto A Viciedo,
Alexandra B Pitkin,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Amy W Yan Mai,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie Bodnar,
Barbara A Burke,
Barbara J Maulfair,
Barbara L Rellahan, PhD,
Burnell M Henry,
Byungja E Marciante,
Cara M Minelli,
Christian D Lynch (CDL),
Christina N Maurino,
Christopher J Adams,
Comyar Shoghi,
Craig W Swanson,
Creighton T Tuzon,
Daniel J Grabicki,
Dave M Deroche,
Dawn L Wydner,
Deborah B Nixon,
Decarlos A Gomez,
Denise M Visco, Investigator,
Diane M Gubernot,
Donna D Gallien, MPH,
Doretha M Tonkins,
Doretha M Wilson,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Edward Oshaughnessy,
Emily A Walters,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Eufemia G Gonzalez,
Frank J Marciniak,
Gail L Katz,
Gene D Arcy,
Gerald Mierle,
Gianine E Delade,
Gianine E Tompkins,
Helen B Ricalde,
Helen Verdel,
Herrmann,
J David Doleski,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
Jean M Kelahan,
Jeffrey J Ebersole,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Joan A Loreng,
Joanne Pryzbylik,
Jonee J Mearns,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Juanita P Versace,
Julie D Bringger,
Justine Tomasso,
Karen E D'orazio,
Keith M Reilly,
Kelli F Dobilas,
Kelly Doremus,
Kelly I Anderson,
Kelly L Anderson,
Kerry A Kurdilla,
Kimberly M Bigler,
King,
Kinh Q Mac,
Kip J Hanks,
Kristy A Zielny,
Laurissa S Flowers,
Laverne Puckett,
Lawrence H Howell,
LCDR Debra Emerson,
Leeterry Moore,
Li Li,
Liatte Kreuger, PharmD,
Linda S Mattingly,
Lisa Harlan,
Lisa Mathew,
Luis A Carrion,
Maira P Brading,
Marion Michaelis,
Mariza M Jafary,
Marjorie D Schultz,
Martha T Olone,
Mary Alice Papdimitriou,
Mary T Carden,
Matthew J Gretkierewicz,
Meihong Liu,
Melba T Rivera,
Melba Trivera Clavell,
Melissa A Freeman,
Melissa A Zuppe,
Melissa B Libby,
Michael Serrano,
Michelle L Johnson,
Mizanne E Lewis,
Nancy L Meade,
Nancy L Rolli,
Nerizza B Dalena,
Nerizza B Guerin,
Niraj Mehta,
Omotunde O Osunsanmi,
Paul L Bellamy,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Qiao Y Bobo,
Raymond W Brullo,
Regina T Brown,
Remache,
Richard D Manney,
Robert G Ruff,
Robert S Sweeton,
Roger J Adams,
Ronnie E Jackson,
Rose M Ashley,
Sandra Kershaw,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Shelley H Beausoleil,
Sherri J Liu,
Sheryl A Kochman,
Shirley H Isbill,
Sidney B Priesmeyer,
Simone E Pitts,
Sinai Davis,
State Agency,
Stephanie T Durso,
Steven S Wahl,
Susant Hadman,
Tania E Vizcaino,
Tania Y Hall,
Tara G Bizjak,
Teresita C Mercado,
Thomas J Arista,
Timothy P Lafave,
Valerie C Reed,
Vien Q Le,
Wayne J Meyer,
William R Chang,
Young M Yoon,
Yung W Chan,
Yvonne C Wilkes
Ana S Cabrera's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2000 | EIR | Becton Dickinson & Company - EIR, 2000-03-31 |
| January, 2001 | EIR | Torrance Memorial Medical Center - EIR, 2001-01-25 |
| March, 2000 | FDA 483 | Becton Dickinson & Company - Form 483, 2000-03-31 |
| September, 2000 | EIR | Hoffmann La Roche Inc - EIR, 2000-09-27 |
| April, 2001 | FDA 483 Response | Central Jersey Blood Center, Inc. - Form 483R, 2001-04-28 |
| July, 2001 | FDA 483 | Ortho-Clinical Diagnostics, Inc. - Form 483, 2001-07-27 |
| August, 2000 | FDA 483 | Musculoskeletal Transplant Foundation - Form 483, 2000-08-22 |
| January, 2001 | FDA 483 | Torrance Memorial Medical Center - Form 483, 2001-01-25 |
| October, 2000 | EIR | Howmedica Osteonics Corp - EIR, 2000-10-12 |
| April, 2001 | FDA 483 | Central Jersey Blood Center, Inc. - Form 483, 2001-04-09 |
| January, 2001 | FDA 483 Response | Torrance Memorial Medical Center - Form 483R, 2001-02-19 |
| July, 2001 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2001-07-27 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more